Related Experiment Videos
Pathogenesis of onchocercal keratitis (River blindness)
1Departments of Medicine and Ophthalmology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Clinical Microbiology Reviews
|July 10, 1999
Summary
Onchocercal keratitis, a leading cause of blindness from Onchocerca volvulus, involves an inflammatory response to parasite antigens in the eye. Understanding these immune mechanisms may lead to new interventions for this parasitic eye disease.
Area of Science:
- Ophthalmology
- Immunology
- Parasitology
Background:
- Onchocerciasis, caused by Onchocerca volvulus, affects 17 million people and is a major cause of blindness.
- Ocular pathology in onchocerciasis can affect any part of the eye, with anterior segment disease including keratitis.
- Onchocercal keratitis results from an inflammatory response in the anterior eye, often leading to corneal opacification and neovascularization.
Purpose of the Study:
- To review current knowledge on human onchocercal keratitis.
- To summarize immunological mechanisms underlying interstitial keratitis using experimental models.
- To explore potential avenues for immunologically based interventions.
Main Methods:
- Review of existing literature on human onchocercal keratitis.
- Analysis of studies using experimental models to investigate interstitial keratitis.
- Examination of the role of host inflammatory response, T helper cells, cytokines, and chemokines in pathogenesis.
Main Results:
- The pathogenesis of onchocercal keratitis is linked to the host inflammatory response to degenerating parasites.
- Soluble O. volvulus antigens induce corneal opacification and neovascularization, mimicking clinical symptoms.
- Experimental models highlight the critical role of sensitized T helper cells and cytokines in regulating corneal inflammation.
Conclusions:
- Onchocercal keratitis is driven by the host's immune response to parasite antigens.
- Cytokines and chemokines play significant roles in inflammatory cell recruitment to the cornea.
- Further research into the molecular basis of onchocercal keratitis could inform novel immunotherapeutic strategies.